Observational studyPloS one2026
Clinical evaluation of the i-gel Plus supraglottic airway in Japanese patients: A prospective observational study.
Observational study in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe i-gel® Plus, a new supraglottic airway, has a high oropharyngeal leak pressure of 32 ± 7 cmH2O in the European population. Because the i-gel® series was developed based on the laryngeal anatomy in Western populations, its performance in other regions, such as East Asia, is unknown. Therefore, we aimed to perform an initial clinical evaluation of i-gel® Plus in Japanese patients.
methodsThis prospective observational study, conducted from March to June 2024 at a university hospital in Japan, recruited a total of 64 adult patients, 16 each of nonelderly (18-69 years) male, nonelderly female, elderly (≥ 70 years) male, and elderly female patients. Patients with a suspected high risk of aspiration or a predicted difficult airway were excluded. We recorded the oropharyngeal leak pressure (primary outcome), first-attempt success rate, and fiberoptic views of the i-gel® Plus. Continuous variables were evaluated for normality using the Shapiro-Wilk test and Q-Q plot. The groups were stratified by age and sex for exploratory analysis.
resultsOf the 67 enrolled patients, three were excluded: one 70-year-old male because of failed ventilation and two because of missing data. Finally, 64 patients were analyzed, with 16 patients in each age-sex group. The oropharyngeal leak pressure was 23.7 ± 6.9 (mean ± standard deviation) cmH2O, which was normally distributed based on the Shapiro-Wilk normality test (P = 0.593) and Q-Q plot. The first-attempt success rate was 92% (including one failed ventilation case), and visible vocal cords were observed in 80% of cases. In exploratory comparisons by sex, male patients had lower oropharyngeal leak pressure and fewer visible vocal cords than female patients.
conclusionsThe i-gel® Plus showed a high first-attempt success rate of 92%; however, its oropharyngeal leak pressure was lower than expected at 23.7 ± 6.9 cmH2O in this Japanese cohort.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.